The registry data suggest improved outcomes without safety concerns, but confirmatory RCTs are needed, a researcher says.
The Breakthrough Device Designation for LVO Stroke represents the latest achievement in Ceribell’s continued efforts to extend its point-of-care EEG brain monitoring technology to additional ...
Zacks Investment Research on MSN
CBLL wins FDA breakthrough status for AI-based LVO stroke detection
CeriBell Inc. CBLL recently announced that the FDA has granted Breakthrough Device Designation for its Large Vessel Occlusion ...
Ceribell announced today that the FDA granted breakthrough device designation for its large vessel occlusion (LVO) stroke ...
An algorithm developed by faculty at The University of Texas Health Science Center at Houston (UTHealth) can help physicians outside of major stroke treatment centers assess whether a patient ...
21d
Health Canada authorizes TNKase(R) (tenecteplase) for the treatment of Acute Ischemic Stroke (AIS)
The approval marks the first new stroke treatment authorized in nearly 27 years, offering an additional option for managing acute ischemic stroke in Canada. MISSISSAUGA, ON, Dec. 17, 2025 /CNW/ - ...
Please provide your email address to receive an email when new articles are posted on . Risk scores and machine learning algorithms were less accurate at predicting stroke for Black adults than for ...
Treatment of acute stroke, before a distinction can be made between ischemic and hemorrhagic types, is challenging. Whether very early blood-pressure control in the ambulance improves outcomes among ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback